Title : Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4.

Pub. Date : 2015 Oct 2

PMID : 26430725






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Rate of CRL4(CRBN) substrate Ikaros and Aiolos degradation underlies differential activity of lenalidomide and pomalidomide in multiple myeloma cells by regulation of c-Myc and IRF4. Lenalidomide interleukin 17 receptor B Homo sapiens